Table IV.

Effect of RCOL administration on anti-fatigue indicators in the serum samples and quadriceps femoris tissue of mice.

Sample	Parameter	Control	EE	RCOL-L	RCOL-M	RCOL-H
Serum	CK, U/ml	0.77±0.20	2.16±0.25a	1.79±0.08b	1.55±0.05b	1.27±0.13b
Quadriceps femoris	LA, mmol/g prot	0.51±0.07	1.29±0.19a	1.00±0.083b	0.75±0.07b	0.69±0.06b
Quadriceps femoris	LDH, U/g prot	1.26±0.11	1.98±0.18a	1.76±0.08b	1.60±0.12b	1.55±0.12b
Quadriceps femoris	MDA, nmol/mg prot	2.95±0.37	6.03±0.61a	4.91±0.06b	4.48±0.14b	3.93±0.33b
Quadriceps femoris	SOD, U/mg prot	158.77±12.95	87.86±5.21a	110.82±5.94b	121.68±6.77b	140.39±4.14b
Quadriceps femoris	CAT, U/mg prot	18.50±3.14	4.18±1.64a	6.68±2.25	7.71±1.90c	14.44±3.12b
Quadriceps femoris	T-AOC, U/mg prot	0.67±0.06	0.28±0.03a	0.37±0.03b	0.46±0.04b	0.55±0.02b

Data are presented as the mean ± SD. n=8.

^aP<0.01 vs. Control;

^bP<0.01 and

^cP<0.05 vs. EE. RCOL, Rhodiola crenulata oral liquid; EE, exhaustive exercise; L, low dose; M, medium dose; H, high dose; prot, protein; CK, creatine kinase; LA, lactic acid; LDH, lactate dehydrogenase; MDA, malondialdehyde; SOD, superoxide dismutase; CAT, catalase; T-AOC, total antioxidative capability.